Abstract:Diabetic neuropathy is one of the prevalent and debilitating microvascular complications of diabetes mellitus, affecting a significant portion of the global population. Relational preclinical animal models are essential to understand its pathophysiology and develop effective treatments. This abstract provides an overview of current knowledge and advancements in such models. Various animal models have been developed to mimic the multifaceted aspects of human diabetic neuropathy, including both type 1 and type 2 diabetes. These models involve rodents (rats and mice) and larger animals like rabbits and dogs. Induction of diabetic neuropathy in these models is achieved through chemical, genetic, or dietary interventions, such as diabetogenic agents, genetic modifications, or high-fat diets. Preclinical animal models have greatly contributed to studying the intricate molecular and cellular mechanisms underlying diabetic neuropathy. They have shed light on hyperglycemia-induced oxidative stress, neuroinflammation, mitochondrial dysfunction, and altered neurotrophic factor signaling. Additionally, these models have allowed for the investigation of morphological changes, functional alterations, and behavioral manifestations associated with diabetic neuropathy. These models have also been crucial for evaluating the efficacy and safety of potential therapeutic interventions. Novel pharmacological agents, gene therapies, stem cell-based approaches, exercise, dietary modifications, and neurostimulation techniques have been tested using these models. However, limitations and challenges remain, including physiological differences between humans and animals, complex neuropathy phenotypes, and the need for translational validation. In conclusion, preclinical animal models have played a vital role in advancing our understanding and management of diabetic neuropathy. They have enhanced our knowledge of disease mechanisms, facilitated the development of novel treatments, and provided a platform for translational research. Ongoing efforts to refine and validate these models are crucial for future treatment developments for this debilitating condition.

From Animal Models to Clinical Practicality: Lessons Learned from Current Translational Progress in Diabetic Peripheral Neuropathy Research

Systematic review of translational insights: Neuromodulation in animal models for Diabetic Peripheral Neuropathy

Treatment for Diabetic Peripheral Neuropathy: What have we Learned from Animal Models?

Research('s) Sweet Hearts: Experimental Biomedical Models of Diabetic Cardiomyopathy

Peripheral Neuropathy Phenotyping in Rat Models of Type 2 Diabetes Mellitus: Evaluating Uptake of the Neurodiab Guidelines and Identifying Future Directions

Current advancement in the preclinical models used for the assessment of diabetic neuropathy

Future Perspective of Diabetic Animal Models

Diet-Induced Rodent Models of Diabetic Peripheral Neuropathy, Retinopathy and Nephropathy

Navigating Preclinical Models and Medications for Peripheral Neuropathy: A Review

Animal Models of Diabetic Neuropathic Pain

Diabetic neuropathy research: from mouse models to targets for treatment

Animal Research for Type 2 Diabetes Mellitus, Its Limited Translation for Clinical Benefit, and the Way Forward

An Overview Of Valuable Scientific Models For Diabetes Mellitus

Innovative Microfluidic Technologies in Precision Research and Therapy Development in Diabetic Neuropathy: a Narrative Review

Recent Advances in Animal Models of Diabetic Nephropathy

Evolving concepts on the role of dyslipidemia, bioenergetics, and inflammation in the pathogenesis and treatment of diabetic peripheral neuropathy

Recent Advances in Biomolecular Patho-Mechanistic Pathways behind the Development and Progression of Diabetic Neuropathy

How inflammation dictates diabetic peripheral neuropathy: An enlightening review

Mouse Models for Studying Diabetic Nephropathy

Preclinical Models for Type 1 Diabetes Mellitus - A Practical Approach for Research

Advances of traditional Chinese medicine preclinical mechanisms and clinical studies on diabetic peripheral neuropathy